Diffusion Pharmaceuticals Net Tangible Assets

Diffusion Pharmaceuticals (DFFN) currently reports a net tangible assets of $23M as of June 2026. That compares with $33M in the prior-year period — down 31.3% year over year. Use the charts on this page to explore Diffusion Pharmaceuticals's net tangible assets history and peer comparisons.

Diffusion Pharmaceuticals's net tangible assets decreased from $33M to $23M — a 31.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Diffusion Pharmaceuticals reported $23M in net tangible assets as of June 2026. That compares with $33M in the prior-year period — down 31.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $23M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Diffusion Pharmaceuticals, and consider following DFFN for alerts when major investors trade the stock.

Diffusion Pharmaceuticals is classified in the Healthcare sector. On net tangible assets, it currently shows $23M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DFFN with unrelated industries.